Corrected: Lilly upped its offer for Morphic by $11 per share, documents show

Industry insiders love to say biotechs are bought, not sold.

That appears to be the case with autoimmune drug developer Morphic Therapeutic, which is trying …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Comprehensive study provides new understandings of genomic influences on neuropsychiatric disease

A new analysis has revealed detailed information about genetic variation in brain cells that could open new avenues for the targeted treatment of diseases such

May 24, 2024

Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer – Biotech Investments

EQS-News: Evotec SE / Key word(s): Personnel Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer 23.04.2024 / 20:40 CET/CEST The issuer is solely

April 24, 2024

Biotech industry worries over potential for RFK Jr. ally as FDA pick

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.